Related Experiment Video
Updated: Jun 17, 2025

Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Investigating the Effect of Dexmedetomidine in Controlling Postoperative Emergence Agitation in Children under
Mitra Golmohammadi1, Shahryar Sane1, Somayeh Ghavipanjeh Rezaei2
1Department of Anesthesiology Urmia University of Medical Sciences, Urmia, Iran.
Insights
Dexmedetomidine significantly reduced emergence agitation (EA) and pain in children after anesthesia. However, it may delay emergence from anesthesia, requiring careful consideration of its use.
Area of Science:
- Anesthesiology
- Pediatric Surgery
- Pharmacology
Background:
- Emergence agitation (EA) is a common complication following general anesthesia in children.
- Sevoflurane anesthesia is frequently used in pediatric procedures, but can be associated with EA.
Purpose of the Study:
- To investigate the efficacy of dexmedetomidine in controlling emergence agitation in children.
- To assess the impact of dexmedetomidine on pain, analgesic consumption, and side effects during emergence from sevoflurane anesthesia.
Main Methods:
- A randomized, double-blind, placebo-controlled trial involving 76 children aged 2-7 years undergoing elective adenoidectomy/tonsillectomy.
- Patients received either dexmedetomidine (0.5 μg/kg) or placebo (normal saline) infusion ten minutes after intubation.
- Agitation was assessed using a four-point scale, and pain was evaluated with the FLACC scale.
Main Results:
- Dexmedetomidine significantly reduced agitation and pain scores in the Post Anesthesia Care Unit (PACU), except at 40 minutes post-PACU admission.
- Analgesic (pethidine) and antiemetic (metoclopramide) use was lower in the dexmedetomidine group.
- Increased incidence of shivering and hypotension requiring intervention was observed in the dexmedetomidine group compared to placebo.
Conclusions:
- A perioperative infusion of 0.5 μg/kg dexmedetomidine effectively reduces emergence agitation, pain, and postoperative nausea and vomiting in children.
- Dexmedetomidine administration may lead to delayed emergence from anesthesia.
- The findings support dexmedetomidine as a potential agent for managing EA, balanced against potential delays in recovery.
Introduction:
Emergence agitation (EA) is one of the common problems during recovery from general anesthesia, especially in children. In this study, we investigated the effect of dexmedetomidine on the control of agitation after anesthesia with sevoflurane in children.
Method:
This randomized control-placebo, double-blind prospective clinical trial was conducted on seventy-six children between 2 and 7 years with ASA (American Society of Anesthesiologists) class I who were candidates for elective adenoidectomy surgery and tonsillectomy. Participants were selected by an available sampling method. Patients were randomly placed in one of the two groups D (dexmedetomidine 0.5 μg/kg infusion within ten minutes) or P (placebo: normal saline infusion within ten minutes). A four-point scale evaluated agitation. Pain evaluation was done by FLACC (faces, legs, activity, cry, and consolability). The statistical software was SPSS version 23. P < 0.05 was considered statistically significant.
Results:
The level of agitation was significantly lower in the intervention group (P < 0.05), except after 40 minutes in the PACU (Post Anesthesia Care Unit) (P=1.00). Patients in the control group experienced high pain scores when admitted at PACU, 10, 20, and 30 minutes after admission at PACU (P < 0.05). Pethidine and metoclopramide prescriptions in the intervention group were lower than in the control group (P < 0.05). Shivering occurred in five patients in the intervention group and nine in the control groups (P=0.032). Hypotension that required intervention occurred in 3 patients in the intervention group and one in the control group (P=0.024).
Conclusion:
Our trial demonstrated that the prescription of 0.5 μg/kg of dexmedetomidine within ten minutes after intubation significantly reduced the EA frequency, pain severity, analgesic consumption, and PONV (postoperative nausea and vomiting). However, it caused delays in the emergence from anesthesia. This trial is registered with IRCT20160430027677N14.
More Related Videos
Related Concept Videos
Parenteral Anesthetics: Overview
Inhalational Anesthetics: Overview
Stages of General Anesthesia
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Pharmocokinetics
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...

